In a shocking development for investors and fans of genetic testing, 23andMe (ME) shares are plummeting, set to open around $1 this Monday morning after the company filed for Chapter 11 bankruptcy.

Strategic comms firm Reevemark is representing 23andMe in its Chapter 11 bankruptcy filing. The human genetics and biotechnology company said on Sunday that it had initiated voluntary Chapter 11 ...

Mark Jensen, 23andMe’s board chair, said in a statement that the company is “committed to continuing to safeguard customer data and being transparent about the management of user data going ...

McCormick reports first-quarter financial results that underwhelm Wall Street. The energy giant said it is targeting hydrocarbon production growth and plans to increase shareholder distributions to 40 ...

GameStop reports its fourth-quarter results after market close on Tuesday amid ongoing chatter that Chief Executive Ryan Cohen could turn the videogame retailer and original meme stock into some form ...

Bay Area News Group: One Bay Area County is Particularly At Risk As Measles Outbreaks Grow In U.S. In the years leading up to 2020, notable progress had been made on childhood vaccination rates ...

Investors face uncertainty regarding their stakes in 23andMe. The potential for recovery or further losses heavily depends on how effectively management can steer the company through this challenging ...

Erginbilgiç’s can-do approach is en vogue in Europe as capitals across the continent ramp up defence spending in response to pressure from US President Donald Trump. The calls to action have lifted ...